Opendata, web and dolomites

JPCOFUND2 SIGNED

ERA-NET to support the Joint Programming in Neurodegenerative Diseases strategic plan (JPND)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 JPCOFUND2 project word cloud

Explore the words cloud of the JPCOFUND2 project. It provides you a very rough idea of what is the project "JPCOFUND2" about.

alignment    strategy    society    proposals    2019    synergies    personalised    interoperable    accelerate    coming    strategies    defragmentation    progression    discovery    actions    jpnd    carers    highest    horizon    2020    funds    national    medicine    competitive    participating    created    area    people    diagnosis    platforms    accessible    calls    aligning    grand    infrastructure    efforts    cumulated    education    collaborative    co    double    global    disease    continue    jpcofund    platform    successes    almost    dementia    capacities    pilot    establishing    neurodegenerative    stop    47    explored    neurodegeneration    earlier    scaling    countries    training    reference    amongst    2011    enhanced    care    benefits    tackling    living    prevention    links    24    supportive    expand    databases    consolidate    patients    million    worldwide    treatments    nearly    ec    capacity    132m    transnational    launching    jpi    innovation    diseases    building    prevent    earmarked    parallel    lacking   

Project "JPCOFUND2" data sheet

The following table provides information about the project.

Coordinator
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 

Organization address
address: RUE DE TOLBIAC 101
city: PARIS
postcode: 75654
website: www.inserm.fr

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country France [FR]
 Total cost 33˙438˙899 €
 EC max contribution 11˙010˙911 € (33%)
 Programme 1. H2020-EU.3.1.1. (Understanding health, wellbeing and disease)
 Code Call H2020-SC1-2018-Single-Stage-RTD
 Funding Scheme ERA-NET-Cofund
 Starting year 2019
 Duration (year-month-day) from 2019-01-01   to  2023-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) coordinator 59˙812.00
2    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) participant 2˙486˙611.00
3    MINISTERO DELLA SALUTE IT (ROMA) participant 880˙707.00
4    NORGES FORSKNINGSRAD NO (OSLO) participant 844˙820.00
5    UNITED KINGDOM RESEARCH AND INNOVATION UK (SWINDON) participant 844˙820.00
6    AGENCE NATIONALE DE LA RECHERCHE FR (PARIS) participant 639˙596.00
7    SCHWEIZERISCHER NATIONALFONDS ZUR FORDERUNG DER WISSENSCHAFTLICHEN FORSCHUNG CH (Bern) participant 516˙462.00
8    MINISTRY OF EDUCATION YOUTH AND SPORTS CZ (Prague) participant 434˙372.00
9    VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL SE (STOCKHOLM) participant 434˙372.00
10    ZORGONDERZOEK NEDERLAND ZON NL (DEN HAAG) participant 434˙372.00
11    Ministrstvo za izobrazevanje, znanost in sport SI (Ljubljana) participant 318˙394.00
12    FONDS VOOR WETENSCHAPPELIJK ONDERZOEK-VLAANDEREN BE (BRUSSEL) participant 311˙238.00
13    SUOMEN AKATEMIA FI (HELSINKI) participant 270˙193.00
14    INNOVATIONSFONDEN DK (KOBENHAVN K) participant 265˙036.00
15    INSTITUTO DE SALUD CARLOS III ES (MADRID) participant 265˙036.00
16    NARODOWE CENTRUM NAUKI PL (KRAKOW) participant 229˙149.00
17    MINISTERO DELL'ISTRUZIONE, DELL'UNIVERSITA' E DELLA RICERCA IT (ROMA) participant 223˙991.00
18    OSTERREICHISCHE FORSCHUNGSFORDERUNGSGESELLSCHAFT MBH AT (WIEN) participant 217˙186.00
19    TURKIYE BILIMSEL VE TEKNOLOJIK ARASTIRMA KURUMU TR (ANKARA) participant 208˙626.00
20    FONDS NATIONAL DE LA RECHERCHE LU (ESCH-SUR-ALZETTE) participant 188˙103.00
21    THE HEALTH RESEARCH BOARD IE (DUBLIN) participant 175˙790.00
22    FUNDACAO PARA A CIENCIA E A TECNOLOGIA PT (LISBOA) participant 147˙059.00
23    NEMZETI KUTATASI FEJLESZTESI ES INNOVACIOS HIVATAL HU (BUDAPEST) participant 147˙059.00
24    VALSTS IZGLITIBAS ATTISTIBAS AGENTURA LV (RIGA) participant 147˙059.00
25    MINISTRY OF HEALTH IL (JERUSALEM) participant 126˙126.00
26    FONDS DE LA RECHERCHE SCIENTIFIQUE- FNRS BE (BRUXELLES) participant 106˙014.00
27    FUNDO REGIONAL PARA A CIENCIA E TECNOLOGIA PT (PONTA DELGADA) participant 64˙969.00
28    FONDATION DE COOPERATION SCIENTIFIQUE MALADIE D'ALZHEIMER ET MALADIES APPARENTEES FR (PARIS) participant 23˙925.00
29    CANADIAN INSTITUTES OF HEALTH RESEARCH CA (OTTAWA ONTARIO) participant 0.00

Map

 Project objective

Worldwide, nearly 47 million people are currently estimated to be living with dementia, and the number is expected to almost double every 20 years, yet treatments that prevent or stop the progression of neurodegeneration are still lacking. Tackling this grand challenge requires enhanced coordination of national efforts to accelerate discovery. Such synergies have been created among 30 countries in the pilot EU JPI on Neurodegenerative Disease Research (JPND). JPND has a long standing experience in collaborative actions; since 2011, a cumulated funding of 132M€ has been dedicated to competitive transnational calls and JPND is now a reference for European and global knowledge and as an innovation platform in the area of neurodegenerative diseases. Building on earlier successes of the JPND Research Strategy in scaling-up and establishing synergies with Horizon 2020, there is a need to continue previous efforts to consolidate the JPND successes in defragmentation, better coordination and alignment amongst the countries, by developing new links with the EC. JPcofuND 2 aims at launching in 2019 an ambitious call for proposals on personalised medicine, where the benefits for the patients affected with neurodegenerative diseases will be explored through personalised diagnosis, personalised prevention and personalised care. Participating countries have earmarked 24,7 M€ of national funds for this call. Moreover, to expand the impact of the project, JPND will continue to implement other actions without EU co-funding such as aligning national research strategies, making databases more accessible and interoperable, developing enabling capacities such as supportive infrastructure and platforms, capacity building, education and training. These actions are required in parallel to achieve the highest impact for the patients, their carers and for society as whole and address this grand challenge in the coming years.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "JPCOFUND2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "JPCOFUND2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.1.)

UNITI (2020)

Unification of treatments and Interventions for Tinnitus patients

Read More  

DC-ren (2020)

Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren)

Read More  

ARREST-TB (2019)

Accurate, Rapid, Robust and Economical diagnostic technoliogieS for Tuberculosis

Read More